We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-3.11%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.4B
AUM Growth
-$526M
Cap. Flow
+$279M
Cap. Flow %
1.3%
Top 10 Hldgs %
19.79%
Holding
3,307
New
142
Increased
1,419
Reduced
1,480
Closed
171

Sector Composition

Rank Sector Weight
1 Technology 10.11%
2 Financials 4.79%
3 Consumer Discretionary 4.07%
4 Healthcare 3.88%
5 Industrials 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REFR icon
3101
Research Frontiers
REFR
$16.8M
$13K ﹤0.01%
12,166
SLQT icon
3102
SelectQuote
SLQT
$124M
$13K ﹤0.01%
10,992
-36,500
-77% -$55.1K
GAN
3103
DELISTED
GAN Ltd
GAN
$12K ﹤0.01%
+10,513
New +$16.5K
SCWO icon
3104
374Water
SCWO
$40.6M
$12K ﹤0.01%
1,000
EGIO
3105
DELISTED
Edgio, Inc. Common Stock
EGIO
$12K ﹤0.01%
342
-9
-3% -$282
ORGS
3106
DELISTED
Orgenesis Inc. Common Stock
ORGS
$11K ﹤0.01%
+1,833
New +$16.4K
VCSA
3107
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$11K ﹤0.01%
1,215
+250
+26% +$3.04K
DOYU
3108
DouYu International Holdings
DOYU
$138M
$10K ﹤0.01%
+1,050
New +$11K
LODE icon
3109
Comstock
LODE
$265M
$10K ﹤0.01%
2,400
SENS icon
3110
Senseonics Holdings Inc
SENS
$419M
$10K ﹤0.01%
826
-50
-6% -$690
SHCR
3111
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$10K ﹤0.01%
10,200
OMIC
3112
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$10K ﹤0.01%
878
SONX
3113
DELISTED
Sonendo, Inc.
SONX
$10K ﹤0.01%
12,980
-1,000
-7% -$1.1K
ACB
3114
Aurora Cannabis
ACB
$237M
$9K ﹤0.01%
1,545
-244
-14% -$1.42K
TPET icon
3115
Trio Petroleum
TPET
$11.2M
$9K ﹤0.01%
750
INO icon
3116
Inovio Pharmaceuticals
INO
$79.6M
$8K ﹤0.01%
1,708
-509
-23% -$2.81K
CURI icon
3117
CuriosityStream
CURI
$166M
$7K ﹤0.01%
10,125
-208
-2% -$182
VWE
3118
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$6K ﹤0.01%
+10,800
New +$9.08K
DTIL icon
3119
Precision BioSciences
DTIL
$205M
$5K ﹤0.01%
508
USAS
3120
Americas Gold and Silver
USAS
$1.75B
$5K ﹤0.01%
5,147
+107
+2% +$102
BMTX.WS
3121
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$5K ﹤0.01%
73,400
ASXC
3122
DELISTED
Asensus Surgical, Inc.
ASXC
$5K ﹤0.01%
20,075
+4,843
+32% +$1.76K
AQB icon
3123
AquaBounty Technologies
AQB
$7.1M
$4K ﹤0.01%
850
+349
+70% +$2.06K
GETR
3124
DELISTED
Getaround, Inc.
GETR
$4K ﹤0.01%
11,000
NVOS
3125
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$4K ﹤0.01%
+1,450
New +$2.65K

Similar funds

Cambridge Investment Research Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Cambridge Investment Research Advisors held 3,307 positions worth $21.4B, down 2.4% from $21.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q3 2023 filing shows 142 new, 1,419 increased, 1,480 reduced and 171 closed positions. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 139,542 shares worth $6.12M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $46.5M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q3 2023 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 139,542 shares worth $6.12M.
  • Cambridge Investment Research Advisors added most to iShares 0-1 Year Treasury Bond ETF in Q3 2023, an estimated $69.3M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $46.5M.
  • Cambridge Investment Research Advisors fully exited Invesco S&P SmallCap Quality ETF in Q3 2023, selling an estimated $4.88M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.4B portfolio in Q3 2023.
  • Cambridge Investment Research Advisors opened 142 new positions and closed 171 in Q3 2023.
  • Cambridge Investment Research Advisors's portfolio value fell 2.4% quarter-over-quarter to $21.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.